If all things go well, the Pfizer-BioNTech Covid-19 vaccine will receive EUA from the U.S. Food and Drug Administration around December 10 or within a few days after, and the Moderna vaccine will receive EUA around December 17 or within a few days after.
Report: AstraZeneca’s Covid-19 Vaccine Generates Antibodies and T-Cells Against the Virus in Phase I Trial
"Operation Warp Speed" Initiative, Antibodies, Clinical Trials, Coronavirus Disease 2019 (COVID-19), COVID-19 Vaccines, Data, Oxford University’s Jenner Institute, R&D, Shares, T-Cells, The Lancet, The Telegraph, United KingdomPhase I data from the Covid-19 vaccine under development by AstraZeneca and Oxford University’s Jenner Institute is showing a robust defense against the novel coronavirus that has infected more than 13 million people across the globe.
In order to generate more shots on goal in the development of a vaccine for COVID-19, the U.S. government will provide funds for the development of three vaccine programs against the disease.
‘Operation Warp Speed’ Narrows List of Potential COVID-19 Vaccine Candidates
"Operation Warp Speed" Initiative, Biomedical Advanced Research and Development Authority (BARDA), Business, Clinical Trials, Coronavirus Disease 2019 (COVID-19), Coronavirus Vaccines, Oxford University, Oxford University’s Jenner Institute, R&D, White HouseLess than one month after the White House zeroed in on 14 vaccine candidates for COVID-19, the administration narrowed that list to five potential treatments for the prevention of the novel coronavirus.
There are more than 70 groups worldwide rushing to develop a vaccine against COVID-19, including Moderna, Johnson & Johnson, Pfizer and BioNTech, Novavax and many others. One of the groups that appears to be ahead of the race is not a commercial biopharma company: Oxford University’s Jenner Institute.